- Language
About Dr Steven Boyages
MB BS PhD FRACP FAFPHM DDU
Profile: Professor Steven Boyages is currently a senior Endocrinologist in the Department of Endocrinology at Westmead Hospital. He was formerly the Director of the Department of Endocrinology. Steven was previoulsy the Medical Director for eHealth NSW. Previously Steven was the Foundation Chief Executive of the Clinical Education and Training Institute (CETI) of NSW. Steven was formerly the Chief Executive of the Sydney West Area Health Service (SWAHS) and has professorial appointments to the University of Sydney and the University of Western Sydney. In the former role as CE of SWAHS employed over 15,000 staff, covers a population of 1.2 million people and has a gross operating budget of $2.0 billion and manages $ 1.6 billion worth of assets. The Area extended from Auburn to Lithgow local government authorities approximately the size of Holland. He was appointed CEO of the former Western Sydney AHS in 2002. The AHS was broken into two local health networks at the end of 2010 as part of the National Health Reform agenda. Steven is a unique hybrid of clinician manager who continues to work in the clinical field of endocrinology. He was previously the Director of Diabetes and Endocrinology at Westmead Hospital from 1990 to 1999. In that role his major achievements were to define the pathophysiology of thyroid hormone deficiency on brain development secondary to iodine deficiency; to develop prevention strategies in iodine deficient communities in China, India, Indonesia and Northern Italy; to define the impact of Growth Hormone excess and deficiency in adults and to develop innovative population health models of care for people with diabetes. Steven continues an active research career in a range of domains, but mostly in the pursuit of better models of chronic disease prevention and management. Steven previously was the foundation director of the Centre for Research and Clinical Policy in NSW Health in 1999. During that time he established the Priority Health Programs funded to the tune of $15 million per annum; doubled the Research Infrastructure Grants Program; established the Quality Branch of NSW Health and was appointed as Clinical Advisor to the Director General to implement the Government Action Plan for Health Reform. Steven was also instrumental in establishing and securing funding for the State s biotechnology strategy BioFirst, a $150 million investment. Steven s current interests are varied and include the application of health technology to health care delivery, in particular the development of IT applications that add value to the enterprise, to the community and to the patient. Steven s teams have developed sophisticated web based business information tools that allow real time enterprise monitoring. In addition, Steven has pioneered innovative models of organizational design, and re-engineered clinical models of care. Most importantly his chief interest is providing the best possible care to patients, their carers and to the communities he serves.
Special interests: Thyroid, Pituitary, Diabetes, Insulin Pump Therapy, Osteoporosis, Hormone Replacement Therapy
LANGUAGESGreek
Practice Location
- Practice name Westmead Private Hospital
- Address Suite 3 Westmead Private Hospital, Cnr Mons and Darcy Roads, WESTMEAD, NSW, 2145
- Suburb or City Westmead, NSW
- State New South Wales
- Country Australia
Secondary Practice Location
- Practice name Norwest Private Hospital
- Address Norwest Private Hospital, 9 Norbrik Drive, Bella Vista, NSW
- Suburb or City Bella Vista, NSW
- State New South Wales
- Country Australia
- What is the Dr Steven Boyages's specialty?
- Dr Steven Boyages is a Endocrinologist.
- What is the address of the Dr Steven Boyages's practice?
- Dr Steven Boyages works at Suite 3 Westmead Private Hospital, Cnr Mons and Darcy Roads, WESTMEAD, NSW, 2145
- What are the Dr Steven Boyages's qualifications?
MB BS PhD FRACP FAFPHM DDU
Profile: Professor Steven Boyages is currently a senior Endocrinologist in the Department of Endocrinology at Westmead Hospital. He was formerly the Director of the Department of Endocrinology. Steven was previoulsy the Medical Director for eHealth NSW. Previously Steven was the Foundation Chief Executive of the Clinical Education and Training Institute (CETI) of NSW. Steven was formerly the Chief Executive of the Sydney West Area Health Service (SWAHS) and has professorial appointments to the University of Sydney and the University of Western Sydney. In the former role as CE of SWAHS employed over 15,000 staff, covers a population of 1.2 million people and has a gross operating budget of $2.0 billion and manages $ 1.6 billion worth of assets. The Area extended from Auburn to Lithgow local government authorities approximately the size of Holland. He was appointed CEO of the former Western Sydney AHS in 2002. The AHS was broken into two local health networks at the end of 2010 as part of the National Health Reform agenda. Steven is a unique hybrid of clinician manager who continues to work in the clinical field of endocrinology. He was previously the Director of Diabetes and Endocrinology at Westmead Hospital from 1990 to 1999. In that role his major achievements were to define the pathophysiology of thyroid hormone deficiency on brain development secondary to iodine deficiency; to develop prevention strategies in iodine deficient communities in China, India, Indonesia and Northern Italy; to define the impact of Growth Hormone excess and deficiency in adults and to develop innovative population health models of care for people with diabetes. Steven continues an active research career in a range of domains, but mostly in the pursuit of better models of chronic disease prevention and management. Steven previously was the foundation director of the Centre for Research and Clinical Policy in NSW Health in 1999. During that time he established the Priority Health Programs funded to the tune of $15 million per annum; doubled the Research Infrastructure Grants Program; established the Quality Branch of NSW Health and was appointed as Clinical Advisor to the Director General to implement the Government Action Plan for Health Reform. Steven was also instrumental in establishing and securing funding for the State s biotechnology strategy BioFirst, a $150 million investment. Steven s current interests are varied and include the application of health technology to health care delivery, in particular the development of IT applications that add value to the enterprise, to the community and to the patient. Steven s teams have developed sophisticated web based business information tools that allow real time enterprise monitoring. In addition, Steven has pioneered innovative models of organizational design, and re-engineered clinical models of care. Most importantly his chief interest is providing the best possible care to patients, their carers and to the communities he serves.
Special interests: Thyroid, Pituitary, Diabetes, Insulin Pump Therapy, Osteoporosis, Hormone Replacement Therapy
LANGUAGESGreek
FAQ
Rate this doctor
Loading...